Correlation Between Aurora Cannabis and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Aurora Cannabis and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aurora Cannabis and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aurora Cannabis and Cannara Biotech, you can compare the effects of market volatilities on Aurora Cannabis and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aurora Cannabis with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aurora Cannabis and Cannara Biotech.

Diversification Opportunities for Aurora Cannabis and Cannara Biotech

-0.28

Correlation Coefficient

Aurora Cannabis  Cannara Biotech

Very good diversification

The 3 months correlation between Aurora and Cannara is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Aurora Cannabis and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Aurora Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aurora Cannabis are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Aurora Cannabis i.e., Aurora Cannabis and Cannara Biotech go up and down completely randomly.

Pair Corralation between Aurora Cannabis and Cannara Biotech

Assuming the 90 days trading horizon Aurora Cannabis is expected to under-perform the Cannara Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Aurora Cannabis is 1.84 times less risky than Cannara Biotech. The stock trades about -0.15 of its potential returns per unit of risk. The Cannara Biotech is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  64.00  in Cannara Biotech on September 23, 2024 and sell it today you would earn a total of  11.00  from holding Cannara Biotech or generate 17.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Aurora Cannabis  vs.  Cannara Biotech

Aurora Cannabis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aurora Cannabis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Cannara Biotech

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aurora Cannabis and Cannara Biotech

The main advantage of trading using opposite Aurora Cannabis and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aurora Cannabis position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Aurora Cannabis and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.